Leadership Overview
Worldwide Clinical Trials has 5 executives leading key functions including strategy, operations, human resources, cardiovascular & metabolic business, and oncology.
Driven by a commitment to advancing medical breakthroughs, Worldwide Clinical Trials provides comprehensive preclinical and clinical development services, focusing on critical therapeutic areas to accelerate the delivery of life-changing treatments to patients globally.
Driven by a commitment to advancing medical breakthroughs, Worldwide Clinical Trials provides comprehensive preclinical and clinical development services, focusing on critical therapeutic areas to accelerate the delivery of life-changing treatments to patients globally.
Leadership Roles at Worldwide Clinical Trials
Daniel Gizachew - Chief Executive Officer
Daniel Gizachew, the Chief Executive Officer at Worldwide Clinical Trials, directs the overarching corporate strategy and operational execution for the global contract research organization. Gizachew guides the company's mission to deliver top-performing preclinical and Phase I-IV clinical development services across the biotechnology and pharmaceutical sectors. This leadership role involves fostering innovation and ensuring the efficient delivery of comprehensive clinical experience, from early phase studies through post-approval real-world evidence. Daniel Gizachew's strategic vision shapes the company's expansion into major therapeutic areas, including Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases, driving the organization's impact on advancing global health outcomes. The Chief Executive Officer ensures alignment with market demands and client needs, solidifying Worldwide Clinical Trials' position as a leader in clinical research services.
Alessandra Vignola - President, Cardiovascular & Metabolic Business Unit
Alessandra Vignola, the President, Cardiovascular & Metabolic Business Unit at Worldwide Clinical Trials, directs the strategic growth and operational success of the company's dedicated services for cardiovascular and metabolic indications. Vignola leads the business unit's efforts in providing specialized preclinical and clinical development expertise tailored to these complex therapeutic areas. This executive role involves cultivating client relationships and ensuring the delivery of high-quality, end-to-end clinical trial management, from early phase research to post-approval studies. Alessandra Vignola's leadership focuses on advancing innovative treatments within these critical fields, leveraging the company's extensive experience in bioanalytical sciences and late-phase studies. The President, Cardiovascular & Metabolic Business Unit drives market penetration and service excellence, contributing significantly to Worldwide Clinical Trials' reputation for comprehensive clinical experience and real-world evidence generation in these key areas.
Keya Watkins - President, Oncology
Keya Watkins, the President, Oncology at Worldwide Clinical Trials, spearheads the strategic direction and operational execution for the company's oncology-focused clinical development services. Watkins leads the dedicated teams providing specialized expertise in preclinical research and Phase I-IV clinical trials for cancer therapies. This critical role ensures the seamless delivery of comprehensive services, from early phase bioanalytical sciences through to post-approval studies and real-world evidence generation. Keya Watkins drives the business unit's growth by fostering innovation and maintaining the highest standards of quality and regulatory compliance within the oncology sector. The President, Oncology is instrumental in advancing the company's mission to support the development of life-changing treatments for patients facing various forms of cancer, leveraging Worldwide Clinical Trials' extensive experience in this major therapeutic area. Watkins' leadership ensures robust clinical trial management and strategic client partnerships.
Lisa Skorets - Chief of Staff, Gcd
Lisa Skorets, the Chief of Staff, Gcd at Worldwide Clinical Trials, provides critical operational support and strategic alignment across key business functions. Skorets facilitates the execution of corporate initiatives, ensuring seamless integration between departmental objectives and the company's overall strategic direction. This role involves managing cross-functional projects and driving process improvements to enhance efficiency within the global contract research organization. Lisa Skorets supports the executive leadership team by streamlining communication and resource allocation, particularly in the delivery of preclinical and clinical development services. The Chief of Staff, Gcd plays a vital part in translating high-level strategy into actionable plans, contributing to the company's focus on therapeutic areas such as Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. Skorets ensures operational readiness for all phases of clinical trials, from early development to real-world evidence.
Joy Clark - Chief People Officer
Joy Clark, the Chief People Officer at Worldwide Clinical Trials, architects the human capital strategy to support the company's growth and operational excellence. Clark oversees all aspects of talent management, including recruitment, employee development, and fostering a positive organizational culture that aligns with the company's mission. This leadership position is crucial for attracting and retaining top talent within the biotechnology and pharmaceutical services sector. Joy Clark drives initiatives that enhance employee engagement and ensure the workforce possesses the specialized skills required for preclinical and Phase I-IV clinical development services. The Chief People Officer champions programs that support the company's focus on major therapeutic areas like Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases, ensuring a skilled team is in place for all study phases. Clark's strategic approach to people operations underpins the company's ability to deliver comprehensive clinical experience and real-world evidence.
Explore Leadership Teams in Business Services
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership
YK
Founded in 1930, The Woods Hole Oceanographic Institution is a non-profit organization that supports marine research, engineering, and higher education. Woods Hole Oceanographic Institution is headquartered in Woods Hole, Massachusetts.
Company Leadership FS
KG
SH
KL
The National Laboratory of the Rockies, located in Golden, Colorado, is a national laboratory of the United States Department of Energy specializing in energy systems research and development. Formerly known as the National Renewable Energy Laboratory until December 2025, NLR serves as the primary federal laboratory for advancing energy technologies across the entire energy spectrum, from generation to distribution to end use. The laboratory conducts multidisciplinary research in renewable energy, energy efficiency, energy systems integration, sustainable transportation, bioenergy, photovoltaics, wind energy, hydrogen and fuel cells, energy storage, and advanced materials science. NLR operates state-of-the-art research facilities including the Energy Systems Integration Facility, Solar Energy Research Facility, and maintains high-performance computing capabilities. The laboratory partners with industry, government agencies, academia, and other national laboratories to bridge foundational research with practical applications. NLR develops data sets, analytical tools, and models for energy technology analysis while working to lower energy costs, drive economic growth, strengthen national security, and ensure abundant energy for the nation. The laboratory maintains campuses in Golden and Arvada, Colorado, as well as Fairbanks, Alaska, and is operated under contract for the Department of Energy's Office of Critical Minerals and Energy Innovation by the Alliance for Sustainable Energy.
Company Leadership JL
MH
Seegene was founded in 2000. This company provides the developing of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Their headquarters are located in Seoul, South Korea.
Company Leadership DL
JC
ML
JY
Frequently Asked Questions Regarding Worldwide Clinical Trials Top Executives and Leadership Team
